MXPA05009763A - 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. - Google Patents

2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.

Info

Publication number
MXPA05009763A
MXPA05009763A MXPA05009763A MXPA05009763A MXPA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A
Authority
MX
Mexico
Prior art keywords
benzamid
sulfonylamino
pyridin
methoxy
propyl
Prior art date
Application number
MXPA05009763A
Other languages
English (en)
Spanish (es)
Inventor
Gert Ulrich Kuerzel
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MXPA05009763A publication Critical patent/MXPA05009763A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
MXPA05009763A 2003-03-18 2004-03-05 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. MXPA05009763A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10312073A DE10312073A1 (de) 2003-03-18 2003-03-18 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen
PCT/EP2004/002247 WO2004083157A1 (de) 2003-03-18 2004-03-05 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
MXPA05009763A true MXPA05009763A (es) 2006-01-27

Family

ID=32920928

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009763A MXPA05009763A (es) 2003-03-18 2004-03-05 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.

Country Status (22)

Country Link
EP (1) EP1606237A1 (sr)
JP (1) JP2006520343A (sr)
KR (1) KR20050110681A (sr)
CN (1) CN100361943C (sr)
AR (1) AR043622A1 (sr)
AU (1) AU2004222137A1 (sr)
BR (1) BRPI0408441A (sr)
CA (1) CA2519022A1 (sr)
DE (1) DE10312073A1 (sr)
HK (1) HK1086819A1 (sr)
HR (1) HRP20050815A2 (sr)
MA (1) MA27749A1 (sr)
MX (1) MXPA05009763A (sr)
MY (1) MY176510A (sr)
NO (1) NO20054472L (sr)
NZ (1) NZ542476A (sr)
PE (1) PE20050307A1 (sr)
RS (1) RS20050690A (sr)
RU (1) RU2333202C2 (sr)
TW (1) TW200500342A (sr)
WO (1) WO2004083157A1 (sr)
ZA (1) ZA200506328B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009931A1 (de) * 2004-02-26 2005-09-15 Aventis Pharma Deutschland Gmbh Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
WO2007015775A2 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
JP5685203B2 (ja) 2009-05-29 2015-03-18 ラクオリア創薬株式会社 カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
HK1086819A1 (en) 2006-09-29
NO20054472L (no) 2005-09-27
MY176510A (en) 2020-08-12
RU2005132163A (ru) 2006-04-10
DE10312073A1 (de) 2004-09-30
PE20050307A1 (es) 2005-06-08
CN1756728A (zh) 2006-04-05
CN100361943C (zh) 2008-01-16
NZ542476A (en) 2008-05-30
KR20050110681A (ko) 2005-11-23
TW200500342A (en) 2005-01-01
ZA200506328B (en) 2006-04-26
CA2519022A1 (en) 2004-09-30
HRP20050815A2 (en) 2006-09-30
RU2333202C2 (ru) 2008-09-10
EP1606237A1 (de) 2005-12-21
AR043622A1 (es) 2005-08-03
AU2004222137A1 (en) 2004-09-30
BRPI0408441A (pt) 2006-04-04
RS20050690A (sr) 2008-04-04
JP2006520343A (ja) 2006-09-07
WO2004083157A1 (de) 2004-09-30
MA27749A1 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
RS82003A (en) Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
WO2001066564A3 (en) Gamma-secretase inhibitors
RS37603A (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, theis urse as a medicament and pharmaceutical preparations containing these compounds
YU42503A (sh) Arilovani furan-1 tiofen-amidi-karbonske kiseline sa blokirajućim dejstvom kalijumovog kanala
WO2001064642A3 (en) Benzamides and related inhibitors of factor xa
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
EP1201239A4 (en) CYCLIC AMINES AS CCR3 ANTAGONISTS
BR0210028A (pt) Agentes antibacterianos
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
PT992509E (pt) Novos derivados macrolidos
HK1120794A1 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
IL152337A0 (en) A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
ATE554764T1 (de) Wirkungsvolle vereinfachte derivate von immunosuppressiva
ATE241640T1 (de) Fusidinsäure-derivate
WO2001034553A3 (en) 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration